• Intra-Cellular Therapies average return on assets for 2023 was -23.87, a 43% decline from 2022.
• Intra-Cellular Therapies average return on assets for 2022 was -41.88, a 5.41% decline from 2021.
• Intra-Cellular Therapies average return on assets for 2021 was -39.73, a 11.75% increase from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.